FDA rejects Eli Lilly's arthritis drug

ReutersNewsPublished: April 17, 201712 views
Published: April 17, 2017

Shares of Eli Lilly and partner Incyte drop after the U.S. Food and Drug Administration declines to approve a new drug for rheumatoid arthritis. Roselle Chen reports.

Be the first to suggest a tag